Skip to main content
Log in

Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Citalopram (CIT), is a selective serotonin (5-HT) reuptake blocker and a clinically effective antidepressant. The present electrophysiological studies were undertaken to investigate in vivo the acute and long-term effects of CIT administration on 5-HT neurotransmission. In a first series of experiments, a single dose of CIT (0.05–0.5 mg/kg) was administered intravenously to naive rats while recording the activity of a 5-HT-containing neuron in the nucleus raphe dorsalis. A dose-response relationship of the inhibitory effect of CIT on the firing activity of 5-HT neurons was obtained with an ED50 of 0.23±0.03 mg/kg. In a second series of experiments, rats were treated with CIT (20 mg/kg/day, i.p.) for 2, 7 and 14 days. In rats treated for 2 days, there was a marked reduction in the firing activity of 5-HT neurons in the nucleus raphe dorsalis; there was a partial recovery after 7 days and a complete recovery after 14 days of treatment. The response of 5-HT neurons to intravenously administered LSD was decreased in rats treated for 14 days with CIT, indicating a desensitization of the somatodendritic 5-HT autoreceptor. In a third series of experiments, carried out in rats treated with CIT (20 mg/kg/day, i.p.) for 14 days, the suppression of firing activity of CA3 hippocampal pyramidal neurons produced by microiontophoretically-applied 5-HT and by the electrical activation of the ascending 5-HT pathway was measured. Long-term treatment with CIT did not modify the responsiveness of these neurons to microiontophoretically-applied 5-HT; however, the effect of the electrical activation of the ascending 5-HT pathway on these same neurons was enhanced. To determine if 5-HT reuptake blockade could be responsible for this enhancement, CIT (1 mg/kg) was injected intravenously in naive rats while stimulating the ascending 5-HT pathway; it failed to modify the effectiveness of the stimulation. To assess the involvement of the 5-HT terminal autoreceptor, methiothepin, a 5-HT autoreceptor antagonist, was injected intravenously (1 mg/kg) in naive rats and in rats treated for 14 days with CIT while stimulating the ascending 5-HT pathway. Methiothepin enhanced the effect of the stimulation in naive rats but failed to do so in the CIT-treated rats. It is concluded that long-term CIT treatment enhances 5-HT neurotransmission by desensitizing both the somatodendritic and terminal 5-HT autoreceptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aghajanian GK (1978) Feedback regulation of central monoaminergic neurons: evidence from single-cell recording studies. In: Youdim MBH, Lovenberg W, Lagnado JR, Sharman DF (eds) Essays in Neurochemistry and Neuropharmacology, vol 3. Wiley, New York, pp 1–32

    Google Scholar 

  • Arnt J, Hyttel J, Fredricson Overø K (1983) Prolonged treatment with the specific 5-HT-uptake-inhibitor citalopram. Amphetamine hypersensitivity without receptor changes. Br J Pharmacol 79:411P

  • Arnt J, Hyttel J, Fredricson Overø K (1984a) Prolonged treatment with the specific 5-HT-uptake-inhibitor citalopram: Effect on dopaminergic and serotonergic functions. Pol J Pharmacol Pharm 36:221–230

    Google Scholar 

  • Arnt J, Fredricson Overø K, Hyttel J, Olsen R (1984b) Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram. Psychopharmacology 84:457–465

    Google Scholar 

  • Baumann PA, Waldmeier PC (1984) Negative feedback control of serotonin release in vivo: comparison of 5-hydroxyindoleacetic acid levels measured by voltammetry in concious rats and by biochemical techniques. Neuroscience 11:195–204

    Google Scholar 

  • Biegon A, Rainbow TC, McEwen BS (1982) Quantitative autoradiography of serotonin receptors in the rat brain. Brain Res 242:197–204

    Google Scholar 

  • Blier P, de Montigny C (1983) Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci 3:1270–1278

    Google Scholar 

  • Blier P, de Montigny C, Tardif D (1984) Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat. Psychopharmacology 84:242–249

    Google Scholar 

  • Blier P, de Montigny C (1985) Serotonergic but not noradrenergic neurons in the rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience 16:949–955

    Google Scholar 

  • Cerrito F, Raiteri M (1979) Serotonin release is modulated by presynaptic autoreceptors. Eur J Pharmacol 57:427–430

    Google Scholar 

  • Chaput Y, Blier P, de Montigny C (1986) In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J. Neurosci (in press)

  • Chase TN, Katz RI, Kopin IJ (1969) Release of [3H] serotonin from brain slices. J Neurochem 16:607–615

    Google Scholar 

  • Christensen AV, Fjalland B, Pedersen V, Danneskiold-Samsoe P, Svendsen JM (1977) Pharmacology of a new phtalane (LU 10-171), with specific 5-HT uptake inhibiting properties. Eur J Pharmacol 41:153–162

    Google Scholar 

  • de Montigny C, Aghajanian GK (1977) Preferential action of 5-methoxytryptamine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors: a comparative iontophoretic study with LSD and serotonin. Neuropharmacology 16:811–818

    Google Scholar 

  • Dompert WU, Glaser T, Traber J (1985) 3H-TVXQ 7821: Identification of 5-HT1 binding sites as target for a novel putative anxiolytic. Naunyn-Schmiedeberg's Arch Pharmacol 328: 467–470

    Google Scholar 

  • Engel G, Göthert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332:1–7

    Google Scholar 

  • Farnebo LO, Hamberger B (1971) Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta Physiol Scand 371:35–44

    Google Scholar 

  • Farnebo LO, Hamberger B (1974) Regulation of [3H]5-hydroxytryptamine release from rat brain slices. J Pharm Pharmacol 26:642–644

    Google Scholar 

  • Fjalland B, Christensen AV, Hyttel J (1977) Peripheral and central muscarinic receptor affinity of psychotropic drugs. Naunyn-Schmiedeberg's Arch Pharmacol 301:5–9

    Google Scholar 

  • Fredricson Overø K (1982a) Kinetics of citalopram in test animals: drug exposure in safety studies. Prog Neuro-Psychopharmacol Biol Psychiat 6:297–309

    Google Scholar 

  • Fredricson Overø K (1982b) Kinetics of citalopram in man. Prog Neuro-Psychopharmacol Biol Psychiat 6:311–318

    Google Scholar 

  • Galzin AM, Moret C, Verzier B, Langer SZ (1985) Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus. J Pharmacol Exp Ther 235:200–211

    Google Scholar 

  • Gastpar M, Gastpar G (1982) Preliminary studies with citalopram (LU 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant. Prog Neuro-Psychopharmacol Biol Psychiat 6:319–325

    Google Scholar 

  • Göthert M (1980) Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 314:223–230

    Google Scholar 

  • Gozlan H, Mestikawy SEI, Pichat L, Glowinski J, Hamon M (1983) Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 305:140–142

    Google Scholar 

  • Haigler HJ, Aghajanian GK (1974) Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons and neurons receiving a serotonergic input. J Pharmacol Exp Ther 188:688–699

    Google Scholar 

  • Hall H, Sällemark M, Wedel I (1984) Acute effects of atypical antidepressants on various receptors in the rat brain. Acta Pharmacol Toxicol 54:379–384

    Google Scholar 

  • Hamon M, Bourgoin S, Jagger J, Glowinski J (1974) Effects of LSD on synthesis and release of 5-HT in rat brain slices. Brain Res 69:265–280

    Google Scholar 

  • Hyttel J (1977) Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: LU 10-171. Psychopharmacology 51:225–233

    Google Scholar 

  • Hyttel J (1978) Effect of a specific 5-HT uptake inhibitor, citalopram (LU 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro. Psychopharmacology 60:13–18

    Google Scholar 

  • Hyttel J (1982) Citalopram — pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuro-Psychopharmacol Biol Psychiat 6:277–295

    Google Scholar 

  • Hyttel J, Fredricson Overø K, Arnt J (1984) Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology 83: 20–27

    Google Scholar 

  • Kandel ER, Spencer WA (1961) Electrophysiology of hippocampal neurons. II. After-potentials and repetitive firing. J Neurophysiol 24:243–259

    Google Scholar 

  • Katz RI, Kopin IJ (1969) Effects of D-LSD and related compounds on release of norepinephrine-H3 and serotonin-H3 evoked from brain slices by electrical stimulation. Pharmacol Res Commun 1:54–61

    Google Scholar 

  • Köhler C (1984) The distribution of serotonin binding sites in the hippocampal region of the rat brain. An autoradiographic study. Neuroscience 13:667–680

    Google Scholar 

  • Kragh-Sørensen P (1983) A controlled double-blind multicenter trail comparing chlorimipramine and a new, highly selective 5-HT-uptake-inhibitor, citalopram (LU10-171). Abstract P175. VII World Congress in Psychiatry, Vienna, July 11–16, p 482

  • Kragh-Sørensen P, Fredricson Overø K, Lindegaard Petersen O, Jensen K, Parnas W (1981) The kinetics of citalopram: single and multiple dose studies in man. Acta Pharmacol Toxicol 48:53–60

    Google Scholar 

  • Langer SZ, Moret C (1982) Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus. J Pharmacol Exp Ther 222:220–226

    Google Scholar 

  • Lindegaard Pedersen O, Kragh-Sørensen P, Bjerre M, Fredricson Overø K, Gram LF (1982) Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect — a phase II study. Psychopharmacology 77:199–204

    Google Scholar 

  • Maître L, Baumann PA, Jackel J, Waldmeier PC (1982) 5-HT uptake inhibitors: pharmacological and neurobiochemical criteria of selectivity. In: Ho BT, Schoolar JC, Usdin E (eds) Serotonin in biological psychiatry. Raven Press, New York, pp 229–246

    Google Scholar 

  • Martin LL, Sanders-Bush E (1982) Comparison of the pharmacological characteristics of 5-HT1 and 5-HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Naunyn-Schmiedeberg's Arch Pharmacol 321:165–170

    Google Scholar 

  • Melzacka M, Rubak A, Adamus A, Daniel W (1984) Distribution of citalopram in the blood serum and in the central nervous system of rats after single and multiple dosage. Pol J Pharmacol Pharm 36:675–682

    Google Scholar 

  • Middlemiss DN (1984a) 8-Hydroxy-2-(di-n-propylamino)tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between autoreceptor and the [3H]5-HT recognition site. Naunyn-Schmiedeberg's Arch Pharmacol 327:18–22

    Google Scholar 

  • Middlemiss DN (1984b) Stereoselective blockade at [3H]5-HT binding sites at the 5-HT autoreceptor by propranol. Eur J Pharmacol 101:289–293

    Google Scholar 

  • Moret C (1985) Pharmacology of the serotonin autoreceptor. In: Green AR (ed) Neuropharmacology of serotonin. Oxford University Press, Oxford, pp 21–49

    Google Scholar 

  • Øfsti E (1982) Citalopram — a specific 5-HT-reuptake inhibitor — as an antidepressant drug: A phase II multicenter trial. Prog Neuro-Psychopharmacol Biol Psychiat 6:327–335

    Google Scholar 

  • Pawlowski L, Nowak G, Górka Z, MazelaH (1985) Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: Effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities. Psychopharmacology 86:156–163

    Google Scholar 

  • Pettitbone DJ, Pflueger BA (1984) Effects of methiothepin and lysergic acid diethylamide on serotonin release in vitro and serotonin synthesis in vivo: possible relation to serotonin autoreceptor function. J Neurochem 43:83–90

    Google Scholar 

  • Ropert R, Lôo H, Gay C (1984) Etude préliminaire en ouvert d'un nouveau composé antidépresseur: le citalopram. Encéphale 10:131–134

    Google Scholar 

  • Scuvée-Moreau J, Dresse AR (1979) Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat. Eur J Pharmacol 57:219–225

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chaput, Y., de Montigny, C. & Blier, P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 333, 342–348 (1986). https://doi.org/10.1007/BF00500007

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00500007

Key words

Navigation